hydroxychloroquine and febuxostat

hydroxychloroquine has been researched along with febuxostat in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Abedi, SM; Alizadeh-Navaei, R; Davoodi, L; Hosseinimehr, SJ; Khorasani, G; Rouhanizadeh, H; Salehifar, E	1

Reviews

1 review(s) available for hydroxychloroquine and febuxostat

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for hydroxychloroquine and febuxostat

Article	Year
Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial. International journal of clinical practice, 2020, Volume: 74, Issue:11 Topics: Adult; Aged; Ambulatory Care; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Administration Schedule; Febuxostat; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020

Article

Year

Febuxostat therapy in outpatients with suspected COVID-19: A clinical trial.

International journal of clinical practice, 2020, Volume: 74, Issue:11

Topics: Adult; Aged; Ambulatory Care; Antiviral Agents; Betacoronavirus; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Drug Administration Schedule; Febuxostat; Female; Humans; Hydroxychloroquine; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome

2020